http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8651626

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Research Support, Non-U.S. Gov't
issn 1471-2407
issueIdentifier 1
pageRange 214-
publicationName BMC Cancer
startingPage 214
bibliographicCitation Legge F, Paglia A, D'Asta M, Fuoco G, Scambia G, Ferrandina G. Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. BMC Cancer. 2011 May 31;11():214. PMID: 21627839; PMCID: PMC3123659.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8cdb508ac26bb8d26646f77b90456ec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09412032fbaa7a1a3398d9f28ddb39ae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5009c132b834869e68dd8fa98aaad628
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27f4ba5e92bfdd65abf28f7818648f6e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe1fa1d267457e4fb579f065cbe2ae6d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_819a70521fa2be94c5509cf474d75432
date 2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/1471-2407-11-214
https://pubmed.ncbi.nlm.nih.gov/21627839
https://pubmed.ncbi.nlm.nih.gov/PMC3123659
isPartOf https://portal.issn.org/resource/ISSN/1471-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language English
source https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
discusses http://id.nlm.nih.gov/mesh/M0024707
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0356369
http://id.nlm.nih.gov/mesh/M0271306
http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0276185
http://id.nlm.nih.gov/mesh/M0018226
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7519
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25e7482d087cb6429609f07a507aa159
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129347572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129202881

Total number of triples: 53.